Bigirumurame

Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy

Association between maternal adiposity measures and infant health outcomes: A systematic review and meta-analysis

Innovative trial approaches in immune-mediated inflammatory diseases: Current use and future potential

*BMC Rheumatology* 2021; 5:21

Medication errors and adverse drug events in a UK hospital during the optimisation of electronic prescriptions: A prospective observational study

*Lancet Digital Health* 2019; 1(8):e403-e412

Antibiotic-loaded bone cement is associated with a lower risk of revision following primary cemented total knee arthroplasty

*The Bone & Joint Journal* 2019; 101-B(11):1331-1347

Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom

*Alimentary Pharmacology & Therapeutics* 2018; 48(9):951-960

Can testing clinical significance reduce false positive rates in randomized controlled trials? A snap review

*BMC Research Notes* 2017; 10:775

Detection of lung cancer through metabolic changes measured in blood plasma

*Journal of Thoracic Oncology* 2016; 11(4):516-523

Using transcriptomics to guide lead optimization in drug discovery projects: Lessons learned from the QSTAR project

*Drug Discovery Today* 2015; 20(5):505-513